Kite Pharma (KITE) Sucessfully Defends Roberts Patent, to Appeal USPTO Decision on Patent on Select CD28 CAR-T Products
Tweet Send to a Friend
Kite Pharma, Inc. (Nasdaq: KITE) today announced several updates to its broad intellectual property portfolio relating to the use of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
